Myciclib 125mg tablet is a targeted therapy containing the active constituent palbociclib. It belongs to the group of anticancer medications known as a cyclin-dependent kinase inhibitors. It is used in treating hormone receptor-positive, human epidermal growth factor 2 negative advanced or metastatic (has spread to other parts of the body) breast cancer. Cancer is a condition in which cells multiply in an uncontrolled and abnormal manner. It is given in combination with certain other anticancer medications.
The common side effects that are likely to associate with Myciclib 125mg tablet are nausea, vomiting, diarrhea, tiredness, hair loss, dry skin, rash, infections, nose bleed, decreased appetite, low blood cell counts, swelling of lips and mouth, changes in taste, dry eye, blurred vision, and increased tearing. Inform your doctor if any of these side effects disturb or persists in you.
Inform your healthcare provider if you are allergic to Myciclib 125mg tablet and its ingredients. Before taking this medicine, it is vital to inform your doctor if you have any signs of infections (fever, chills, or sore throat), liver disorders, kidney disorders, or intolerance to some sugars. Consult your physician immediately if you experience symptoms such as dry cough, chest pain, difficulty breathing, as it could indicate lung inflammation. Make sure you inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start treatment with this medication. Use effective birth control during the treatment and at least three weeks after the last dose. It is not recommended for adolescents and children under 18 years of age.
Uses of Myciclib 125mg TabletTreatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced or metastatic breast cancer. Therapeutic Effects of Myciclib 125mg Tablet
Myciclib 125mg tablet works by blocking the protein called cyclin-dependent kinases 4 and 6, which are vital for the division and growth of cells. By blocking these proteins, this medication slows the growth and prevents the cancer cells from spreading. Interaction of Myciclib 125mg Tablet with other drugsInform your doctor about any medications you are taking or have taken before the treatment. Concurrent use of Myciclib 125mg tablet with CYP3A4 inhibitors such as fentanyl has reported in increased fentanyl toxicity.More Information about Myciclib 125mg Tablet Keep Myciclib 125mg tablet out of sight and reach of children.Store at 20°C to 25°C.How to consume Myciclib 125mg TabletTake Myciclib 125mg tablet exactly as prescribed by your doctor. Take this medication once a day at the same time with food. Swallow this capsule as a whole with a glass of water. Avoid crushing, breaking, or chewing the capsule.Safety Advices for Myciclib 125mg Tablet
Pregnancy
It is not recommended to take Myciclib 125mg tablet during pregnancy as it can harm the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and for at least three weeks after treatment.
Breast Feeding
It is not recommended to take Myciclib 125mg tablet while breastfeeding as it is not known whether it passes into the breast milk.
Lungs
Inform your physician if you have any lung disorders before taking Myciclib 125mg tablet, as it should be used with caution in lung disorder patients.
Liver
Inform your physician if you have any liver disorders before taking Myciclib 125mg tablet, as it should be used with caution in liver disorder patients.
Alcohol
It is unknown whether it is safe to drink alcohol while taking Myciclib 125mg tablet. Check with your doctor for advice.
Driving
It is unknown whether Myciclib 125mg tablet alters driving ability. However, if you experience side effects like tiredness or drowsiness, avoid driving and using machines.
Side Effects of Myciclib 125mg TabletSide effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.Serious:
- Blood disorder (fever, chills, shortness of breath, weakness, bleeding, or bruising)
- Lung inflammation (chest pain, dry cough, or difficulty breathing)
Common:
- Tiredness
- Hair loss
- Dry skin, rash
- Infections
- Low blood cell counts
- Decreased of appetite
- Nausea, vomiting
- Diarrhea
- Swelling of lips and mouth
- Changes in taste
- Nose bleed
- Dry eye, blurred vision, increased tearing
Word of AdviceDuring Myciclib 125mg tablet treatment, it is advised to avoid grapefruit and its juices and preparations containing St. John's wort. It is recommended to use effective birth control while receiving treatment as well as for at least three weeks after the final dose for females and at least fourteen weeks after the final dose for males. This medication may reduce fertility, so discuss with the physician if you have any concerns. Your doctor may recommend regular blood tests to determine whether Myciclib 125mg tablet affects your blood cells.FAQs Q 1. Is Myciclib 125mg tablet targeted therapy?Yes, Myciclib 125mg tablet is a targeted therapy. This medication belongs to the class of cyclin-dependent kinase inhibitors.
Q 2. Do you lose hair on Myciclib 125mg tablet?Yes, Taking Myciclib 125mg tablet can cause hair loss or hair thinning. It is one of the side effects of this medication. Consult your doctor if any side effects disturb you.
Q 3. Can children use Myciclib 125mg tablet?No, Myciclib 125mg tablet is not recommended for adolescents and children under 18.
Q 4. Does Myciclib 125mg tablet affect fertility?Yes, Myciclib 125mg tablet may reduce fertility in men. It may affect your ability to become a father and a child. Hence, men should consider sperm preservation before taking this medication.
Q 5. Does Myciclib 125mg tablet affect blood cell count?Myciclib 125mg tablet might reduce the number of white blood cells and weaken the immune system. It could lead to an increase in the risk of infections. Regular blood tests while taking Myciclib 125mg tablet are advised.
Fact Box of Myciclib 125mg TabletMolecule name: Palbociclib | Therapeutic class: Antineoplastic agents |
Pharmacological class: Anticancer agents | Indications: 1. Hormone receptor (HR)-positive 2. Human epidermal growth factor 2 (HER2)-negative advanced or metastatic breast cancer. |
| Dosage form: Tablets | Habit forming: No |
